Medical Management of Psychotropic Side Effects

CHF 121.95
Auf Lager
SKU
AFCU55SF73Q
Stock 1 Verfügbar
Geliefert zwischen Mo., 27.04.2026 und Di., 28.04.2026

Details

This book is a practical guide for psychiatrists to use when treating patients for medical issues. Over the past 10-20 years, the number of medications prescribed for psychiatric illnesses has steadily increased, and psychiatric practitioners are frequently called upon to manage medical issues and side effects that result from psychotropic treatment. Covering a wide range of conditions from thyroid disorders to cardiac disease, this book is a helpful resource for understanding common adverse medical effects that occur when psychotropic drugs are administered. Presented in a practical format, each chapter discusses management of a particular medical problem or side effect and then provides a summary and flowchart of the major points highlighted in that chapter. Each chapter contains an overview of key medications causing a particular side effect. The book also includes special topics such as psychotropic prescribing in medical illness and tips on electrocardiographic interpretation. This easy-to-reference book aims to bridge the gap between medicine and psychiatry by elaborating on medical conditions seen in routine outpatient psychiatric practice. It serves as an invaluable tool for mental health providers, nurses, health educators, and pharmacologists alike.

Serves as a quick medical guide for psychiatrists addressing side effects of psychotropic drugs in their patients Each chapter outlines a different medical condition, discussing management and treatment Case-based approach provides a comprehensive look at particular clinical scenarios

Autorentext
Aniyizhai Annamalai MBBS, MD Assistant Professor of Psychiatry and of Internal Medicine Yale School of Medicine New Haven, CT, USA

Inhalt
Section I.- Chapter1 Psychotropic prescribing in medically ill patients. -Section II Metabolic syndrome.- Chapter 2 Obesity.- Chapter 3 Diabetes mellitus and acute hyperglycemia.- Chapter 4 Hypertension and acute hypertensive crisis.- Chapter 5 Hyperlipidemia.- Section III Cardiovascular system.- Chapter 6 Orthostatic hypotension.- Chapter 7 Tachycardia and myocarditis.- Chapter 8 QTc prolongation.- Chapter 9 Non-QT conduction abnormalities.- Chapter 10 Peripheral edema.- 11 Appendix - miscellaneous electrocardiographic abnormalities.- Section IV Endocrine system.- Chapter 12 Hyperprolactinemia.- Chapter 13 Thyroid disorders.- Chapter 14 Hypercalcemia.- Section V Kidney and electrolytes.- Chapter 15 Diabetes insipidus.- Chapter16 Hyponatremia.- Chapter 17 Chronic kidney disease.- Section VI Genitourinary system.- Chapter 18 Sexual dysfunction.- Chapter 19 Urinary incontinence and retention.- Section VII Oral and gastrointestinal system.- Chapter 20 Hepatitis.- Chapter 21 Pancreatitis.- 22 Constipation.- 23 Sialorrhea.- 24 Bruxism.- Section VIII Hematologic system.- 25 Introduction to blood cell disorders.- Chapter 26 Leukopenia.- Chapter 27 Platelet function disorders.- Chapter 28 Thrombocytopenia.- Chapter 29 Anemia.- Chapter 30 Pancytopenia.- Chapter 31 Leukocytosis.- Chapter 32 Eosinophilia.- Section IX Dermatology.- Chapter 33 Drug-induced cutaneous reactions.- Section X Neurologic system.- Section X A Movement disorders.- Chapter 34 Introduction to movement disorders.- Chapter 35 Tremor.- Chapter36 Extrapyramidal symptoms I (Parkinsonism).- Chapter 37 Extrapyramidal symptoms II (Dystonia, akathisia, tardive dyskinesia).- Chapter 38 Tics.- Section X B Systemic syndromes.- Chapter 39 Myoclonus and serotonin syndrome.- Chapter 40 Creatine kinase elevation and neuroleptic malignant syndrome.- Section X C Other neurologic conditions.- Chapter 41 Seizures.- Chapter 42 Altered mental status.- Section XI Others.- Chapter 43 Xerostomia.- Chapter 44 Sedation.- Chapter 45 Priapism.- Chapter 46 Polycystic ovarian syndrome.- Chapter 47 Osteoporosis.- Chapter 48 Drug-induced lupus.- Chapter 49 Cataracts.- Chapter 50 Nephrolithiasis.

Weitere Informationen

  • Allgemeine Informationen
    • GTIN 09783319510248
    • Sprache Englisch
    • Größe H235mm x B155mm x T18mm
    • Jahr 2017
    • EAN 9783319510248
    • Format Kartonierter Einband
    • ISBN 331951024X
    • Veröffentlichung 07.04.2017
    • Titel Medical Management of Psychotropic Side Effects
    • Autor Aniyizhai Annamalai
    • Gewicht 493g
    • Herausgeber Springer
    • Anzahl Seiten 324
    • Lesemotiv Verstehen
    • Genre Medical Books

Bewertungen

Schreiben Sie eine Bewertung
Nur registrierte Benutzer können Bewertungen schreiben. Bitte loggen Sie sich ein oder erstellen Sie ein Konto.
Made with ♥ in Switzerland | ©2025 Avento by Gametime AG
Gametime AG | Hohlstrasse 216 | 8004 Zürich | Schweiz | UID: CHE-112.967.470
Kundenservice: customerservice@avento.shop | Tel: +41 44 248 38 38